Cancer Weekly articles from May 1992

Cancer Weekly archives from May 1992

Agency initiates Breast Cancer Prevention Trial. (tamoxifen) (U.S. National Cancer Institute)
May 4, 1992... U.S. NCI Dr. Samuel Broder, director of the U.S. National Cancer Institute (NCI), announced April 29, 1992, the commencement of the Breast Cancer Prevention Trial (BCPT). The BCPT is a $60 million U.S. government study that will follow...

Mammography and new treatments highlight conference. (25th National Conference on Breast Cancer)
May 4, 1992... 25th National Conference on Breast Cancer A report that mammography improves survival in young women with breast cancer, and another finding the procedure to be cost effective highlighted the American College of Radiology's 25th National...

PCR may help in evaluating breast cancer. (polymerase chain reaction) (University of South Florida)
May 4, 1992... Florida University of South Florida (USF), Tampa, Florida, researchers are investigating whether a new, more sensitive method of detecting microscopic traces of cancer in breast lymph nodes can help physicians better define which cancers...

Study says emotional stress does not make breast cancer recur. (England)
May 4, 1992... England British researchers have completed a study that debunks a widespread belief that stress can cause breast cancer to recur. Dr. Jennifer Barraclough said women who suffered from severe stress, such as the death of a loved one,...

Phase II results with breast cancer drug TLC D-99 announced. (Liposome Co.)
May 4, 1992... Liposome Co. The Liposome Co., Inc., Princeton, New Jersey, reported that a high response rate and a good safety profile have been seen with its drug TLC D-99 in a Phase II trial of patients with metastatic breast cancer. In an...

Group says FDA sets double standard on silicone gel breast implants. (Food and Drug Administration) (California Society of Plastic Surgeons)
May 4, 1992... California Society of Plastic Surgeons The following was issued by Collier Communications on behalf of the California Society of Plastic Surgeons: The California Society of Plastic Surgeons Inc. (CSPS) strongly disagrees with the...

Group prevails in suit against governor and Health Services Department chief. (Proposition 99; Pete Wilson, Molly Coye) (American Lung Association of California)
May 4, 1992... American Lung Association of California The Sacramento County (California) Superior Court has ordered Governor Pete Wilson to restore Proposition 99 funding for anti-smoking education in the state and to implement a $16 million...

State health department says smoking linked to one out of five deaths. (California)
May 4, 1992... California Smoking contributed to approximately one out of every five deaths in California during 1988, according to a new report from the California Department of Health Services. The report, "Health and Economic Impact of Smoking,...

Tobacco industry spent $2.7 million in state in 1991. (University of California, San Francisco)
May 4, 1992... University of California, San Francisco The tobacco industry, in an "all-out war" against anti-smoking measures, spent $2.7 million in 1991 on political activity in California, according to the authors of a new report. Tobacco industry...

Statistics indicate 20 percent of pregnant women smoke. (U.S. Department of Health and Human Services)
May 4, 1992... U.S. HHS Despite a slow decline in U.S. infant mortality, one mother in five is increasing the health risks to her baby by smoking during pregnancy, the U.S. government says. The U.S. National Center for Health Statistics, analyzing...

Survey shows tobacco companies' credibility with the public is extremely low. (Sierra Health Foundation)
May 4, 1992... Sierra Health Foundation A new poll of registered voters in Sacramento, California, that surveys public opinion about smoking and public health issues was released by the Sierra Health Foundation, a private, independent, philanthropic...

No need for delay between prostate cancer tests. (digital rectal exam and blood test for prostate-specific antigen) (University of Colorado)
May 4, 1992... University of Colorado Doctors examining men for prostate cancer are only wasting time and money by imposing delays between two common tests for the disease, University of Colorado (CU) researchers reported. Tests on thousands of men...

Many prostate biopsies may be averted with PSA test method. (prostate-specific antigen) (Maryland)
May 4, 1992... Maryland Periodic blood tests can spare many men the cost, discomfort and worry of biopsies to detect prostate cancer, researchers say. The blood tests compare levels of a substance called prostate-specific antigen, or PSA, which is...

Comparison of risk factors in breast cancer. (Research Report)
May 4, 1992... AUTHORS: M. Mitze, M. Schmitt, R. Kreienberg, K. Pollow, H. Graff and P.G. Knapstein. University of Mainz, Mainz, Germany, and the Technical University of Munich, Munich, Germany. According to the authors' abstract of a poster...

Detection of K-ras point mutation from pure pancreatic juice. (Research Report)
May 4, 1992... Comparison of Risk Factors in Breast Cancer AUTHORS: H. Miki, S. Mori, R. Haba, S. Kobayashi, M. Ohmori, H. Miyake and H. Harada. Kagawa Medical School, Kagawa, Japan, and Okayama University Medical School, Okayama, Japan. ...

Mutation in the p53 gene in primary human cervical carcinoma with and without human papilloma virus infection. (Research Report)
May 4, 1992... AUTHORS: M. Fujita, T. Enomoto, M. Inoue, T. Normura and O. Tanizawa. Osaka University Medical School, Osaka, Japan. According to the authors' abstract of a poster presentation to the 83rd annual meeting of the American Association for...

Detectable circulating human interleukin-3 (IL-3) after chemotherapy: evidence for correlation with platelet count. (Research Report)
May 4, 1992... AUTHORS: F.J. Adshead, J.L. Millar, B.C. Millar, D.C. Talbot, M.B. Matson, C.J.M. Davies and I.E. Smith. Institute of Cancer Research and Royal Marsden Hospital, Sutton, Surrey, England According to the authors' abstract of a poster...

Segregation and linkage analyses of human prostate cancer. (Research Report)
May 4, 1992... AUTHORS: B.S. Carter, T.H. Beaty, G.D. Steinberg, B. Childs, G.S. Bova, W.B. Isaacs and P.C. Walsh. Johns Hopkins University, Baltimore, Maryland. According to the authors' abstract of a poster presentation to the 83rd annual meeting...

Cell kinetics of 9200 human breast cancers: consistency of basic and clinical results. (Research Report)
May 4, 1992... AUTHORS: R. Silverstrini, M.G. Daidone, M. Mastore, G. DiFronzo and L. Arboit. National Tumor Institute, Milan, Italy. According to the authors' abstract of a poster presentation to the 83rd annual meeting of the American Association...

Prognostic factors in melanoma progression. (title in error: article is about breast cancer) (Research Report)
May 4, 1992... AUTHORS: L. Wanek, R.M. Elashoff, T. Goradia and D.L. Morton. UCLA School of Medicine, Los Angeles, California, and the John Wayne Cancer Institute, Santa Monica, California. According to the authors' abstract of a poster presentation...

Locoregional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy. (Periodical Report)
May 4, 1992... SOURCE: American Journal of Clinical Oncology, April, 1992;15(2):93-101. A Missouri study concludes that chemotherapy is not routinely indicated in breast cancer patients with locoregional recurrence, and controlled clinical trials are...

Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. (Periodical Report)
May 4, 1992... SOURCE: The Lancet, April 18, 1992;339(8799):943-946. A multicenter study found a strong interaction between serological markers of chronic hepatitis B infection and aflatoxin exposure in liver cancer risk, suggesting that reduction in...

Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. (Periodical Report)
May 4, 1992... SOURCE: Proceedings of the National Academy of Sciences, April, 1992;89:3385-3388. Loss of heterozygosity of regions on 5q including the APC and MCC genetic loci appears to be involved in the development and progression of the majority...

Survival results in adult patients treated for medulloblastoma. (Periodical Report)
May 4, 1992... SOURCE: Cancer, April 15, 1992;69(8):2143-2148. Long-term survival was seen in approximately 50 percent of adults treated for medulloblastoma in a University of Colorado analysis, and researchers concluded that adjuvant chemotherapy did...

Phase II trial of indicine N-oxide in relapsed acute leukemia of childhood. (Periodical Report)
May 4, 1992... SOURCE: American Journal of Clinical Oncology, April, 1992;15(2):135-140. A Childrens Cancer Study Group report indicates that the pyrrolizidine alkaloid indicine N-oxide has some activity in the treatment of childhood acute...

Topics in minority health: behavioral risk factor survey of Chinese - California, 1989. (Periodical Report)
May 4, 1992... SOURCE: Morbidity and Mortality Weekly Report, April 22, 1992. "During the 1980s, Asians/Pacific Islanders were the fastest growing racial/ethnic group in both the United States and California. In Alameda County (which includes Oakland),...

Cancer detection methods highlight meeting. (mammography, ultrasound, magnetic resonance imaging, positron emission tomography) (American Roentgen Ray Society)
May 11, 1992... American Roentgen Ray Society Transvaginal color Doppler ultrasound can help determine which masses in the ovaries are cancer and which are benign, possibly saving patients time and money, a new study has found. Dr. Arthur...

Calcium protective against colon cancer. (Sweden)
May 11, 1992... Sweden A Swedish study adds to the growing evidence that increased consumption of calcium lowers the risk of colon cancer. The study, published in the April 15, 1992, issue of Cancer by researchers at Sweden's University of...

New delivery system to target anticancer chemotherapy. (using low-density lipoproteins) (England)
May 11, 1992... England Cortecs Ltd. researchers report preliminary results in patients of a new delivery system to target antitumor chemotherapy, using low-density lipoprotein (LDL) as a vehicle to achieve selective uptake of a cytotoxic drug by tumor...

Thalidomide shows promise for treating transplant complications. (graft-versus-host disease) (Johns Hopkins University)
May 11, 1992... Johns Hopkins University Thalidomide, the sedative that caused thousands of birth defects in the 1950s and 1960s, may have a new life as treatment for a major complication of bone-marrow transplants, scientists said. Doctors are...

Berkeley physicist dismisses link between electricity and cancer. (J. David Jackson) (University of California)
May 11, 1992... California A University of California at Berkeley physicist said he has found claims linking electricity to cancer are unfounded. J. David Jackson, a particle physicist at the Lawrence Berkeley Laboratory, studied whether low-frequency...

Link between saccharin and human cancer questioned. (University of Nebraska)
May 11, 1992... University of Nebraska The artificial sweetener saccharin probably does not cause cancer in humans, according to a group of University of Nebraska Medical Center researchers who are studying the mechanism by which the sweetener causes...

Survey finds mammography use increasing dramatically. (25th National Conference on Breast Cancer)
May 11, 1992... 25th National Conference on Breast Cancer The use of mammograms has increased dramatically during the past decade, and now at least three-quarters of all older U.S. women have had the X-rays to check for breast cancer, a researcher said....

Panel named to study breast cancer. (Special Commission on Breast Cancer) (U.S. National Cancer Institute)
May 11, 1992... U.S. NCI The President's Cancer Panel has announced the appointment of a 17-member commission to study the state of breast cancer research, prevention, detection and treatment. The commission will address such diverse topics as the...

Self-examination campaign launched. (Skin Cancer Foundation)
May 11, 1992... Skin Cancer Foundation The thrust behind the Skin Cancer Foundation's multifaceted public education initiative is to teach regular self-examination of the skin as an essential weapon in the battle against skin cancer, which afflicts more...

Therapeutic cancer vaccine found to generate significant antibody levels. (Ribi ImmunoChem Research)
May 11, 1992... Ribi ImmunoChem Research A therapeutic cancer vaccine, developed by Biomira Inc. of Edmonton, Alberta, Canada, and incorporating Detox-B adjuvant, was found to generate significant increases in antibody levels, according to the results...

Research agreement with NCI approved for Taxotere. (National Cancer Institute) (Rhone-Poulenc Rorer)
May 11, 1992... Rhone-Poulenc Rorer The U.S. National Cancer Institute (NCI) and the pharmaceutical company Rhone-Poulenc Rorer have approved a Cooperative Research and Development Agreement (CRADA) to test the anticancer drug Taxotere in clinical...

Company receives SBIR grant to develop vaccine for chronic hepatitis B. (Small Business Innovation Research grant) (Cytel Corp.)
May 11, 1992... Cytel Corp. Cytel Corp., San Diego, California, announced that is has received a Small Business Innovation Research (SBIR) Grant from the U.S. National Institute of Allergy and Infectious Disease (NIAID) of the U.S. National Institutes...

Nova Pharmaceutical files new drug application. (Pergamid) (U.S. Food and Drug Administration)
May 11, 1992... U.S. FDA Nova Pharmaceutical Corp., Baltimore, Maryland, announced that the company has filed a new drug application (NDA) seeking U.S. Food and Drug Administration (FDA) marketing approval for Pergamid, a treatment used in conjunction...

Companies to investigate implants of living cells to treat chronic pain. (CytoTherapeutics and Medtronic)
May 11, 1992... CytoTherapeutics and Medtronic The Neurological Division of Medtronic Inc., Minneapolis, Minnesota, and CytoTherapeutics Inc., Providence, Rhode Island, announced that they have signed a research agreement to pursue the use of...

Joint venture formed with Proteus International to develop DNA-binding drugs. (Progene Partners) (Genelabs Technologies)
May 11, 1992... Genelabs Technologies Genelabs Technologies Inc., Redwood City, California, and Proteus International PLC, Cheshire, England, announced the formation of Progene Partners, an equally owned joint venture general partnership based in the...

Enzon Inc. introduces first Pegnology product. (Japan)
May 11, 1992... Japan A therapy utilizing Enzon Inc.'s proprietary technology, Pegnology, is currently being used in Japan for the first time. Enzon, South Plainfield, New Jersey, reported that Adagen, a treatment for a form of Severe Combined...

Company authorized to begin clinical trials of new drug in Canada. (Benzoporphyrin derivative, BPD) (Quadra Logic Technologies Inc.)
May 11, 1992... Quadra Logic Technologies Inc. Quadra Logic Technologies Inc. (QLT), Vancouver, British Columbia, has obtained authorization from the Canadian Health Protection Branch to begin human clinical trials of its proprietary drug, Benzoporphyrin...

Determinants of plasma vitamin E. (Research Report)
May 11, 1992... AUTHORS: R. Sionha, G. Block, B. Patterson, A.H. Mangels, O.A. Lavender and P.R. Taylor. U.S. National Cancer Institute, Bethesda, Maryland. According to the authors' abstract of a poster presentation to the 83rd annual meeting of the...

Human papillomaviruses and the cervical neoplasia continuum among low-income South Carolinians. (Research Report)
May 11, 1992... Determinants of Plasma Vitamin E AUTHORS: A.L. Coker, G.R. Jenkins and L. Pirisi. University of South Carolina at Columbia. According to the authors' abstract of a poster presentation to the 83rd annual meeting of the American...

Immunohistochemical detection of p53 and PCNA overexpression in colorectal tumors. (proliferating cell nuclear antigen) (Research Report)
May 11, 1992... Immunohistochemical Detection of p53 and PCNA AUTHORS: E. Darmon and M.J. Wargovich. M.D. Anderson Cancer Center, Houston, Texas. According to the authors' abstract of a poster presentation to the 83rd annual meeting of the...

Breast cancer incidence and the Pill. (Research Report)
May 11, 1992... AUTHORS: H.H. McDuffie, D. White, D. Robson and L. Tan. University of Saskatchewan, Canada. According to the authors' abstract of a poster presentation to the 83rd annual meeting of the American Association for Cancer Research, to be...

Effect of dietary fiber on colonic bile acids, bacterial enzymes, and diacylglycerol in relation to colon cancer. (Research Report)
May 11, 1992... Breast Cancer Incidence and the Pill AUTHORS: B.S. Reddy, A. Engle and B. Simi. American Health Foundation, Valhalla, New York. According to the authors' abstract of a poster presentation to the 83rd annual meeting of the American...

Detection of anti-p53 antibodies in lung cancer cases and controls. (Research Report)
May 11, 1992... AUTHORS: G.E. Trivers, A. Weston, N.E. Caporaso, P. Friedman, C. Prives, B. Vogelstein, B.F. Trump and C.C. Harris. Laboratory of Human Carcinogenesis, U.S. National Cancer Institute, Bethesda, Maryland. According to the authors'...

National collaborative radiation therapy trials: 3-D dose escalation study for prostate cancer. (National Cancer Institute research grant announcement) (Research Report)
May 11, 1992... AUTHORS: RFA Available: CA-92-05. U.S. National Cancer Institute. "Letter of Intent Receipt Date: June 1, 1992. Application Receipt Date: August 26, 1992. Purpose: The Radiation Research Program (RRP), Division of Cancer Treatment...

Hypothesis driven clinical correlations in hematologic malignancies. (National Cancer Institute research grant announcement) (Research Report)
May 11, 1992... AUTHORS: RFA Available: CA-92-16. U.S. National Cancer Institute. "Letter of Intent Receipt Date: June 17, 1992. Application Receipt Date: September 16, 1992. Purpose: The Cancer Therapy Evaluation Program (CTEP) of the Division of...

Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. (Periodical Report)
May 11, 1992... SOURCE: Journal of the National Cancer Institute, May 6, 1992;84(9):683-689. A Canadian study suggests that breast irradiation significantly reduces local relapse in breast cancer patients, but does not influence survival. The...

Human tumor-associated macrophages are capable of bone resorption. (Periodical Report)
May 11, 1992... SOURCE: British Journal of Cancer, April, 1992;65:523-526. Tumor-associated macrophages (TAMs) may contribute to bone resorption associated with skeletal metastasis, according to a report from Britain's University of Oxford. The...

Hodgkin's disease following non-Hodgkin's lymphoma. (Periodical Report)
May 11, 1992... SOURCE: Cancer, May 1, 1992;69(9):2337-2343. Patients with non-Hodgkin's lymphoma (NHL) are at three-times the risk for Hodgkin's lymphoma than the general population, according to data collected by the U.S. National Cancer Institute's...

Relationship between breast cancer and colorectal adenomatous polyps. (Periodical Report)
May 11, 1992... SOURCE: Cancer, May 1, 1992;69(9):2232-2235. A study by researchers at New York's Columbia University and Mount Sinai School of Medicine suggests that there is no association between the occurrence of breast cancer and colorectal...

Treatment of bone metastases with dichloromethylene bisphosphonate. (Periodical Report)
May 11, 1992... SOURCE: Journal of Clinical Oncology, April, 1992;10(4):591-598. Dichloromethylene bisphosphonate ([CI.sub.2]MDP) showed activity in the treatment of bone metastasis with and without hypercalcemia in an Italian study involving 67 cancer...

Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. (Periodical Report)
May 11, 1992... SOURCE: Journal of Clinical Oncology, April, 1992;10(4):624-630. A treatment protocol including either teniposide or doxorubicin as intensification agents is effective in the inducement of second remissions in children with acute...

Test may detect susceptibility to breast cancer. (Ireland)
May 18, 1992... Ireland American Biogenetic Sciences, Inc. (ABS) has announced the signing of an agreement to acquire worldwide rights to a genetic screening technique that will be developed to detect susceptibility to breast cancer. ABS will...

Group comments on Associated Press mammography story. (reported radiation risks from Canadian study) (American Cancer Society)
May 18, 1992... American Cancer Society Due to a recent Associated Press wire story, women are being misled about the benefits and risks involved in mammography, a life-saving device that can reduce a woman's risk of breast cancer by as much as 30 to 50...

Radiologists defend routine mammograms for young women despite Canadian study. (Massachusetts)
May 18, 1992... Massachusetts A controversial study that found a statistically insignificant risk of cancer deaths among younger women mammogram recipients highlights the uncertainty over when women should begin having the common X-ray tests. The...

Rally held for more breast cancer research money. (Minnesota)
May 18, 1992... Minnesota About 100 people rallied on the Minnesota State Capitol steps to push for more U.S. federal money for breast cancer research, increased accessibility to mammograms and complete healthcare coverage for all breast cancer...

Emotional, legal and medical issues collide on breast implant issue. (American Medical Association)
May 18, 1992... American Medical Association The current controversy over silicone gel breast implants is one in which ideal medical practice conflicts with the reality of patient desires and the profit motive, according to a report published in the May...

Researchers advocate combination of therapies for prostate cancer. (University of Florida)
May 18, 1992... University of Florida A new combination of therapies for advanced prostate cancer appears to reduce the risk of recurrence, according to a new study by University of Florida (UF), Gainesville, Florida, researchers. The researchers...

Drugs more effective than castration in severe prostate cancer. (American Urological Association)
May 18, 1992... American Urological Association Advanced prostate cancer patients treated with two drugs live an average of 10 to 15 months longer than those who undergo castration, a study shows. The study, reported by European scientists at a...

Risk for childhood bone cancer associated with a single defective gene. (p53 mutation) (University of California, San Francisco)
May 18, 1992... California Scientists have reported new evidence that some people are born at higher risk for bone cancer due to a single defective gene present in all the cells of their bodies. Researchers from the Brain Tumor Research Center of...

New approaches to treatment of gliomas studied. (U.S. National Cancer Institute)
May 18, 1992... U.S. NCI Several new strategies for the treatment of gliomas may soon enter clinical trials, according to a report from the U.S. National Cancer Institute (NCI). Two of the strategies involve the use of the herpes simplex virus to...

Test could provide early cancer screening. ("enriched" polymerase chain reaction procedure for detecting mutant genes) (Columbia University)
May 18, 1992... Columbia University Scientists at Columbia University's College of Physicians and Surgeons, New York, have developed a test that eventually could be used to screen patients during the earliest stages of pancreatic, colon and lung...

Study links types of sexual behavior in women to hepatitis B transmission. (U.S. Centers for Disease Control)
May 18, 1992... U.S. CDC New evidence suggests for the first time that women are at greater risk of contracting hepatitis B virus (HBV) if they do not use vaginal contraceptives or if they have anal intercourse, according to a study published in the May...

Company introduces new laser system for the treatment of cancer. (Series 600 Dye Laser) (Laserscope)
May 18, 1992... Laserscope A new laser system for the investigational treatment of cancer, using a photosensitive drug activated by laser light to destroy malignant cells, will be introduced under an agreement signed by Laserscope and PDT Inc. ...

Drug treatment for kidney cancer licensed. (aldesleukin, Proleukin) (U.S. Food and Drug Administration)
May 18, 1992... U.S. FDA The U.S. Food and Drug Administration (FDA) announced the licensing of a genetically engineered product, aldesleukin, for the treatment of metastatic renal cell carcinoma (kidney cancer) in adults. Aldesleukin is the first...

Drug companies combine to market cancer drugs in Asia. (U.S. Bioscience, SmithKline Beecham)
May 18, 1992... U.S. Bioscience, SmithKline Beecham U.S. Bioscience Inc. and SmithKline Beecham said that they have agreed to work jointly in Japan, South Korea and Taiwan to sell drugs used in the treatment of cancer. The agreement involves three...

Center commences safety trials for Cambridge Biotech vaccine adjuvant. (QS-21, Stimulon) (Memorial Sloan-Kettering Cancer Center)
May 18, 1992... Memorial Sloan-Kettering Cancer Center Cambridge Biotech Corp. announced that the Memorial Sloan-Kettering Cancer Center has completed four weeks of a Phase I human clinical trial to evaluate the company's proprietary QS-21 adjuvant,...

Company increases taxol production capacity to 130 kilograms per year. (Hauser Chemical Research)
May 18, 1992... Hauser Chemical Research Hauser Chemical Research Inc. announced the completion of process validation runs at its new production facility in Boulder, Colorado. Process validation is an important step in compliance with standard U.S. Food...

Cancer prevention knowledges and practices of Hispanic subgroups in the United States. (Research Report)
May 18, 1992... AUTHORS: J. Horm, K. Anderson and D. Winn. National Center for Health Statistics, Hyattsville, Maryland. According to the authors' abstract of a poster presentation to the 83rd annual meeting of the American Association for Cancer...

A cytogenetic study in a population exposed to airborne pollutants. (Silesia, Poland) (Research Report)
May 18, 1992... AUTHORS: G. Motykiewicz, J. Michalska, J. Pendzich, F.P. Perera and M. Chorazy. Institute of Oncology, Gilwice, Poland, and Columbia University, New York, New York. According to the authors' abstract of a poster presentation to the...

Cost analysis of hematopoietic growth factors (HGFs) in patients receiving cancer chemotherapy (cc). (Research Report)
May 18, 1992... AUTHORS: G.H. Lyman, C.G. Lyman and R. Sanderson. University of South Florida and the Moffitt Cancer Center, Tampa, Florida. According to the authors' abstract of a poster presentation to the 83rd annual meeting of the American...

Risk of melanoma in melanoma-prone families. (Research Report)
May 18, 1992... AUTHORS: M.A. Tucker, M.C. Fraser, S. Organic and W.H. Clark. U.S. National Cancer Institute, Bethesda, Maryland. According to the authors' abstract of a poster presentation to the 83rd annual meeting of the American Association for...

A prelude to interferon gene therapy for brain tumor. (Research Report)
May 18, 1992... AUTHORS: J. Yoshida, M. Mizuno and K. Yagi. University of Applied Biochemistry, Gifu, Japan. According to the authors' abstract of a poster presentation to the 83rd annual meeting of the American Association for Cancer Research, to be...

Drug resistance in childhood relapsed acute lymphoblastic leukemia. (Research Report)
May 18, 1992... AUTHORS: R. Pieters, E. Lumper, G.J.L. Kaspers, E.R. van Wering, K. Hahlen and A.J.P. Veerman. Free University Hospital, Amsterdam, The Netherlands. According to the authors' abstract of a poster presentation to the 83rd annual meeting...

Phase I evaluation of all-trans-retinoic acid for solid tumor patients. (Research Report)
May 18, 1992... AUTHORS: J.S. Lee, R.A. Newman, S.M. Lippman, C. Craddock, M.N. Raber, I.H. Krakoff and W.K. Hong. M.D. Anderson Cancer Center, Houston, Texas. According to the authors' abstract of a poster presentation to the 83rd annual meeting of...

Histologic grade, DNA content, and image analysis in soft tissue tumors. (Research Report)
May 18, 1992... AUTHORS: Y.Q. Shi, S.L. Cao and S. Li. Shanghai Medical University, Shanghai, China. According to the authors' abstract of a poster presentation to the 83rd annual meeting of the American Association for Cancer Research, to be held May...

Late relapse of malignant germ cell tumors (MGCT). (Research Report)
May 18, 1992... AUTHORS: A.L. Paz, P. Lianes, F. Rivera, I. Mayordomo, R.Hitt and V. Valentin. Oncological Hospital, Madrid, Spain. According to the authors' abstract of a poster presentation to the 83rd annual meeting of the American Association for...

Clinical significance of ras oncogene activation in human lung cancer. (Periodical Report)
May 18, 1992... SOURCE: Cancer Research, May 1, 1992;52:2665s-2669s. Although K-ras has been proposed as a target for antitumor therapy, its major clinical role could be to aid in the selection of patients for specific treatment regimens such as...

Urinary levels of bombesin-like peptides in asymptomatic cigarette smokers: a potential risk marker for smoking-related diseases. (Periodical Report)
May 18, 1992... SOURCE: Cancer Research, May 1, 1992;2727s-2731s. Smokers with increased bombesin-like peptide (BLP) levels may have a greater risk for smoking-related diseases, according to a multicenter study. BLP are neuropeptides produced by...